CV

Capsovision INC

+$20.9M

Net Activity

Institutions Holding

51

Popularity Rank

#5947

Avg Weight

0.00%

Total Value

$29.1M

Ownership Trend

51 institutions currently hold CV, with 44 net buyers and 4 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Significantly Increased

Based on recent trading activity

Net Selling Institutions

4

Net Buying Institutions

44

Key Holders

Key Holders

Top 5 by Value

BI
BlackRock, Inc.
$9.5M
VC
Vanguard Capital Management LLC
$7.5M
GC
Geode Capital Management, LLC
$3.2M
SS
State Street CORP
$1.9M
VP
Vanguard Portfolio Management LLC
$1.2M

Top 5 by Conviction

XT
XTX Topco Ltd
0.01%
AW
Alaska Wealth Advisors, LLC
0.01%
BI
BlackRock, Inc.
0.00%
VC
Vanguard Capital Management LLC
0.00%
GC
Geode Capital Management, LLC
0.00%
View all 51 holding institutions

Quarterly Activity

Recent Activity

+$19.7M

Total Buy Value

$295.5K

Total Sell Value

New buy19
Trim1
Add25
Sold out3

44

Net Buyers

4

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

1

Filings (14d)

Data as of 2026-07-02
2026-07-02

CapsoVision appointed Dr. David S. Shields, a gastroenterologist with decades of experience in capsule endoscopy, as a Class I director and Compensation Committee member on July 1, 2026, filling the vacancy left by Dr. Joanne Imperial's resignation. Dr. Imperial stepped down from the board but remains as a consultant, earning $600 per hour for up to 5 hours weekly and receiving 10,000 stock options vesting over four years. Dr. Shields will also consult for the company at $600 per hour for up to 3 hours weekly.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

FAQ

Who are the top institutional investors holding CAPSOVISION INC (CV)?
Major stakeholders currently include BlackRock, Inc. ($9.5M), Vanguard Capital Management LLC ($7.5M), Geode Capital Management, LLC ($3.2M). Based on the latest 13F filings, there are a total of 51 tracked investment funds and institutions maintaining positions in CV.
What is the overall institutional sentiment toward CV recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $20.9M, driven by 44 managers accumulating shares while 4 reduced their exposure.
Which institutions have been selling or reducing their CV positions?
In the latest period, 1 funds trimmed their holdings, and 3 managers completely exited their positions. The aggregate reported sell value was $295.5K.
Are there any notable investors adding CV to their portfolios?
Yes, buying activity remains notable. 19 institutions opened new positions in {ticker}, and 25 existing holders added to their shares. The total reported buy value for the quarter amounted to $19.7M.

Related Stocks

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,150

Total reported value

$2.1T

3245 13F institutions increased their position this quarter

View detail
AMZN

Amazon.com INC

Institutions Holding

5,957

Total reported value

$1.5T

3028 13F institutions increased their position this quarter

View detail
NVDA

Nvidia CORP

Institutions Holding

5,764

Total reported value

$3.0T

2743 13F institutions increased their position this quarter

View detail